Duality Biotherapeutics Statistics

Total Valuation

HKG:9606 has a market cap or net worth of HKD 18.87 billion. The enterprise value is 17.40 billion.

Market Cap	18.87B
Enterprise Value	17.40B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

HKG:9606 has 88.04 million shares outstanding.

Current Share Class	88.04M
Shares Outstanding	88.04M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	13.02%
Owned by Institutions (%)	13.70%
Float	31.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.14
PB Ratio	-8.77
P/TBV Ratio	n/a
P/FCF Ratio	62.96
P/OCF Ratio	62.06
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-15.57
EV / Sales	8.42
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	58.04

Financial Position

The company has a current ratio of 0.49

Current Ratio	0.49
Quick Ratio	0.48
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	0.02
Interest Coverage	-748.16

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-6.51%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	10.50%
Revenue Per Employee	12.15M
Profits Per Employee	-6.58M
Employee Count	170
Asset Turnover	1.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	54.63
Average Volume (20 Days)	409,752

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:9606 had revenue of HKD 2.07 billion and -1.12 billion in losses. Loss per share was -139.73.

Revenue	2.07B
Gross Profit	835.02M
Operating Income	-199.04M
Pretax Income	-1.08B
Net Income	-1.12B
EBITDA	-195.51M
EBIT	-199.04M
Loss Per Share	-139.73

Full Income Statement

Balance Sheet

The company has 1.49 billion in cash and 5.63 million in debt, giving a net cash position of 1.48 billion or 16.82 per share.

Cash & Cash Equivalents	1.49B
Total Debt	5.63M
Net Cash	1.48B
Net Cash Per Share	16.82
Equity (Book Value)	-2.15B
Book Value Per Share	-269.73
Working Capital	-2.09B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 304.12 million and capital expenditures -4.34 million, giving a free cash flow of 299.78 million.

Operating Cash Flow	304.12M
Capital Expenditures	-4.34M
Free Cash Flow	299.78M
FCF Per Share	3.41

Full Cash Flow Statement

Margins

Gross margin is 40.42%, with operating and profit margins of -9.63% and -54.11%.

Gross Margin	40.42%
Operating Margin	-9.63%
Pretax Margin	-52.26%
Profit Margin	-54.11%
EBITDA Margin	-9.46%
EBIT Margin	-9.63%
FCF Margin	14.51%

Dividends & Yields

HKG:9606 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-5.92%
FCF Yield	1.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:9606 has an Altman Z-Score of -1.94. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.94
Piotroski F-Score	n/a